Get in on agilon health inc.’s (AGL) buy-in window today!

agilon health inc. (NYSE: AGL) stock fell -3.61% on Tuesday to $19.76 against a previous-day closing price of $20.50. With 1.36 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.86 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $20.59 whereas the lowest price it dropped to was $19.58. The 52-week range on AGL shows that it touched its highest point at $28.36 and its lowest point at $14.36 during that stretch. It currently has a 1-year price target of $27.54.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Price Performance and Earnings:

Three-month performance dropped to -1.94% while six-month performance fell -21.37%. The stock gained 21.08% in the past year, while it has gained 22.43% so far this year. A look at the trailing 12-month EPS for AGL yields -0.27 with Next year EPS estimates of -0.01. For the next quarter, that number is -0.09. This implies an EPS growth rate of -560.10% for this year and 100.00% for next year.

Float and Shares Shorts:

At present, 411.06 million AGL shares are outstanding with a float of 407.24 million shares on hand for trading. On Oct 13, 2022, short shares totaled 22.72 million, which was 5.53% higher than short shares on Sep 14, 2022. In addition to Mr. Steven Jackson Sell as the firm’s Pres, CEO & Director, Mr. Timothy S. Bensley serves as its Chief Financial Officer.


Institutional Ownership:

Through their ownership of 98.73% of AGL’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 49.03% of AGL, in contrast to 43.44% held by mutual funds. Shares owned by individuals account for 12.13%. As the largest shareholder in AGL with 9.79% of the stake, Morgan Stanley Investment Managem holds 40,305,321 shares worth 40,305,321. A second-largest stockholder of AGL, Capital Research & Management Co, holds 34,433,560 shares, controlling over 8.36% of the firm’s shares. Fidelity Management & Research Co is the third largest shareholder in AGL, holding 33,340,714 shares or 8.10% stake. With a 3.18% stake in AGL, the American Funds Small Cap World Fu is the largest stakeholder. A total of 13,114,300 shares are owned by the mutual fund manager. The American Funds New Economy Fund, which owns about 3.17% of AGL stock, is the second-largest Mutual Fund holder. It holds 13,047,353 shares valued at 210.58 million. Vanguard Health Care Fund holds 2.93% of the stake in AGL, owning 12,060,922 shares worth 194.66 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AGL since 15 analysts follow the stock currently. There are 14 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With AGL analysts setting a high price target of $41.00 and a low target of $21.00, the average target price over the next 12 months is $27.92. Based on these targets, AGL could surge 107.49% to reach the target high and rise by 6.28% to reach the target low. Reaching the average price target will result in a growth of 41.3% from current levels.


EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. AGL will report FY 2022 earnings on 03/01/2024. Analysts have provided yearly estimates in a range of -$0.17 being high and -$0.25 being low. For AGL, this leads to a yearly average estimate of -$0.21. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. agilon health inc. surprised analysts by -$0.02 when it reported -$0.07 EPS against a consensus estimate of -$0.05. The surprise factor in the prior quarter was -$0.03. Based on analyst estimates, the high estimate for the next quarter is -$0.07 and the low estimate is -$0.13. The average estimate for the next quarter is thus -$0.10.

Summary of Insider Activity:

Insiders traded AGL stock several times over the past three months with 17 Buys and 14 Sells. In these transactions, 131,870 shares were bought while 123,572 shares were sold. The number of buy transactions has increased to 73 while that of sell transactions has risen to 82 over the past year. The total number of shares bought during that period was 1,776,898 while 13,287,059 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *